arbekacin has been researched along with Pneumonia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamada, Y; Hirai, J; Mikamo, H; Suematsu, H; Yamagishi, Y | 1 |
Farrell, DJ; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y; Yokota, N | 1 |
3 other study(ies) available for arbekacin and Pneumonia
Article | Year |
---|---|
[Evaluation of six cases of arbekacin inhalation for pneumonia].
Topics: Adult; Aged; Anti-Bacterial Agents; Child; Dibekacin; Female; Humans; Infant; Male; Pneumonia | 2014 |
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia.
Topics: Amikacin; Anti-Bacterial Agents; Dibekacin; Enterobacter; Humans; Klebsiella; Microbial Sensitivity Tests; Pneumonia; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 2015 |
[Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus isolated from patients of a pediatrics ward].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Child; Dibekacin; Humans; Kanamycin Resistance; Methicillin Resistance; Pneumonia; Respiratory System; Staphylococcal Infections; Staphylococcus aureus | 1993 |